Skip to main content
. Author manuscript; available in PMC: 2020 Aug 19.
Published in final edited form as: Psychopharmacology (Berl). 2020 Apr 19;237(6):1873–1883. doi: 10.1007/s00213-020-05505-z

Table 3.

Accuracy (% correct trials), number of correct responses (safe condition: out of 60 trials; threat condition: out of 54 trials), and reaction times (in milliseconds) for N-back performance for participants who were administered placebo (N = 27) and methylphenidate (N = 26). Standard deviations are in parentheses

Condition Placebo Methylphenidate
Safe
1-back
Safe
3-back
Threat
1-back
Threat
3-back
Safe
1-back
Safe
3-back
Threat
1-back
Threat
3-back
Accuracy 93.3 ± (6.7) 73.5 ± (9.2) 93.7 ± (7.9) 73.4 ± (9.2) 95.1 ± (7.7) 72.6 ± (9.9) 93.2 ± (5.6) 75.4 ± (10.5)
No. of correct trials 55.98 ± (4.0) 44.1 ± (5.5) 50.60 ± (4.3) 39.64 ± (5.0) 57.06 ± (4.6) 43.56 ± (5.9) 50.38 ± (3.0) 40.72 ± (5.7)
Reaction times 741 ± (112) 923 ± (260) 731 ± (116) 930 ± (225) 707 ± (176) 895 ± (285) 725 ± (182) 912 ± (303)